ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1945

The Bridge to Adult Care from Childhood for Young Adults with Rheumatic Disease (BACC YARD) Program, a Pediatric-to-Adult Rheumatology Transition Program: 2024 Updates

John Bridges1, Eileen Rife2, Randy Cron3, Livie Timmerman4, Linda McAllister5, Annelle Reed6, Carolyn Smith7, Emily Smitherman3, Matthew Stoll3, Bethany Walker5 and Melissa Mannion3, 1University of Alabama at Birmingham/Children's of Alabama, Birmingham, AL, 2University of Alabama Birmingham, Vestavia Hills, AL, 3University of Alabama at Birmingham, Birmingham, AL, 4University of Alabama at Birmingham, Gardendale, AL, 5Children's of Alabama, Trussville, AL, 6Children's of Alabama, Tuscaloosa, AL, 7Children's of Alabama, Birmingham, AL

Meeting: ACR Convergence 2024

Keywords: Access to care, Health Care, Juvenile Inflammatory Arthritis, Pediatric rheumatology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: Health Services Research – ACR/ARP Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: The transition period from pediatric to adult-oriented rheumatology care is a high-risk time for disease flare and poor outcomes.  We previously demonstrated implementation of a structured transition program from 2020-2022 decreased the time to first adult rheumatology appointment compared to historical controls. Our current study analyzed additional data through 2024 and evaluate follow-up to the subsequent adult rheumatology visit to identify potential opportunies for improvement.   

 

Methods: In 2020 we implemented a specialized transition program structure utilizing dual adult/pediatric rheumatology physicians, the Bridge to Adult Care from Childhood for Young Adults with Rheumatic Disease (BACC YARD) Program.  An adult/pediatric rheumatologist joined the final pediatric rheumatology visit and then followed the patient in the adult rheumatology clinic.  Requested timing for first adult rheumatology visit was determined by joint decision between the adult/pediatric rheumatologist and the childhood pediatric rheumatologist. Follow up to the subsequent adult rheumatology visit (requested versus actual) was assessed and compared by t-test.  A Pareto chart was used to identify the most common causes for delayed ( >30 days) second adult rheumatology visit.  All historical control cohort patients (from between March 1, 2018 and March 1, 2020) identified had at least two pediatric rheumatology visits at Children’s of Alabama prior to transfer and were successfully transferred to University of Alabama at Birmingham (UAB) rheumatology.

Results: The BACC YARD program (7/2020-4/2024) included 162 young adult participants diagnosed with a rheumatic disease in childhood.  83% of participants successfully completed a pre-transfer visit at Children’s of Alabama and a post-transfer visit at UAB by 4/2024.  50% of the participants had a diagnosis of juvenile idiopathic arthritis and 27% had a diagnosis of systemic lupus erythematosus or similar connective tissue disease (Table 1).  The BACC YARD clinic has had 1 patient death and 11 patient pregnancies (6 of which prompted urgent transition to adult rheumatology).  There was a significantly shorter median interval between last pediatric and first adult visit in BACC YARD compared to the historical control cohort (147 days vs 261 days, respectively, p< 0.001; Table 2).  Of those who have attended a second adult rheumatology visit (N=125), 63% of patients (N=79) had visits scheduled within 30 days of their requested follow up time.  50% (N=23) of those attending their second adult rheumatology visit longer than 30 days after the requested date had a single interim canceled visit (Figure 1).

Conclusion: From 2020-2024, the BACC YARD Program significantly reduced median time to first adult visit compared to historical controls and more than half of the successfully transferred patients attended a 2nd adult rheumatology visit on schedule.  Canceled visits and low clinic availability were the primary reasons for delays to second visit and provide opportunities for program improvement. 

Supporting image 1

Table 1: Characteristics of BACC YARD Program Cohort, 7/2020-4/2024 (N=162)

Supporting image 2

Table 2: Median Transfer Intervals (from Last Pediatric Visit to First Adult Visit) in Days, BACC YARD Program Cohort vs Historical Control Cohort

Supporting image 3

Figure 1: Cause for Delayed 2nd Adult Visit (>30 Days after Requested Date) in the BACC YARD Cohort


Disclosures: J. Bridges: None; E. Rife: None; R. Cron: AbbVie/Abbott, 1, Pfizer, 1, Sobi, 1, 5; L. Timmerman: None; L. McAllister: None; A. Reed: None; C. Smith: None; E. Smitherman: None; M. Stoll: None; B. Walker: None; M. Mannion: NIAMS K23AR081410, 5, Rheumatology Research Foundation, 5.

To cite this abstract in AMA style:

Bridges J, Rife E, Cron R, Timmerman L, McAllister L, Reed A, Smith C, Smitherman E, Stoll M, Walker B, Mannion M. The Bridge to Adult Care from Childhood for Young Adults with Rheumatic Disease (BACC YARD) Program, a Pediatric-to-Adult Rheumatology Transition Program: 2024 Updates [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/the-bridge-to-adult-care-from-childhood-for-young-adults-with-rheumatic-disease-bacc-yard-program-a-pediatric-to-adult-rheumatology-transition-program-2024-updates/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-bridge-to-adult-care-from-childhood-for-young-adults-with-rheumatic-disease-bacc-yard-program-a-pediatric-to-adult-rheumatology-transition-program-2024-updates/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology